EP12.01. Aumolertinib Combination SBRT Treated EGFR Co-mutation Patients with Symptomatic Brain Metastases: A Case Report - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Xiaojuan Zhang
Meta Tag
Speaker Xiaojuan Zhang
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
metastatic non-small cell lung cancer
symptomatic brain metastases
third-generation EGFR tyrosine kinase inhibitor
disease progression
stereotactic body radiation therapy
neurological symptoms
prolongation of survival
EGFR-mutated NSCLC
Powered By